Latest Dilution News

WAM Microcap Limited has announced a fully franked dividend of AUD 0.0535 per share for the half-year ending December 2025, offering shareholders a dividend reinvestment plan with a 2.5% discount.

Goodman Group reported a slight dip in operating profit for the half year ended 31 December 2025, while statutory profit rose and the total portfolio value expanded to $87.4 billion. The group maintained its interim distribution at 15 cents per security amid ongoing investment in logistics and digital infrastructure.

Spheria Emerging Companies Limited has reported a solid 16.8% increase in profit after tax for the half-year ending December 2025, alongside a strategic shift introducing monthly fully franked dividends.

AuMEGA Metals has successfully upsized its institutional financing to C$30.1 million, anchored by Condire Investors who will hold nearly 20% of the company. The funds will accelerate exploration programs across its Newfoundland gold projects.

Orthocell has secured a $3 million R&D tax refund, lifting its cash reserves to nearly $50 million and reinforcing its financial strength as it pushes commercialisation of its nerve repair product Remplir™ across key global markets.

Albright Metals has agreed to sell a significant portion of its Bryah Basin tenements to Catalyst Metals for $1 million cash plus $800,000 in shares, enabling a sharper focus on its Canadian gold and antimony projects.

Marimaca Copper Corp. has launched a significant C$409 million global offering, combining treasury and secondary share sales, to fund key development and exploration activities at its flagship Chilean copper project.

Australian Bond Exchange Holdings Limited (ABE) has had its trading suspension lifted immediately following a capital raising announcement, signaling renewed investor engagement.

Premier1 Lithium has kicked off a significant 3,700-metre drilling program at its Mt Kersey Prospect within the Yalgoo Gold Project, aiming to unlock the potential of a large gold-in-soil anomaly and preserved hydrothermal system in Western Australia.

Stavely Minerals has locked in a $500,000 unsecured director loan facility to fund its 2026 Scoping Study targeting copper, gold, and silver production. This non-dilutive funding move underscores confidence from within the board as the company advances key projects.

Nexalis Therapeutics has completed a key capital raising milestone, issuing new shares, options, and performance rights following shareholder approval. This move supports the company’s clinical-stage drug development programs targeting pain and mental health.

Elementos Limited has raised $29.5 million through a strategic placement to L1 Capital, strengthening its financial position as it pushes forward with key tin projects in Spain and Tasmania.